TY - JOUR
T1 - Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy
AU - Cilingiroglu, Mehmet
AU - Chilakapati, Venkata
AU - Dunlap, Stephanie
AU - Leesar, Massoud A.
PY - 2010/4
Y1 - 2010/4
N2 - Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).
AB - Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).
KW - Cardiac allograft vasculopathy
KW - Drug-eluting stent
KW - Restenosis
KW - Stent fracture
UR - http://www.scopus.com/inward/record.url?scp=77949895316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949895316&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2009.08.001
DO - 10.1016/j.carrev.2009.08.001
M3 - Article
C2 - 20347805
AN - SCOPUS:77949895316
SN - 1553-8389
VL - 11
SP - 120
EP - 123
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 2
ER -